BioCentury
ARTICLE | Financial News

Gene therapy play AAVLife secures $12 million

April 15, 2014 11:30 PM UTC

AAVLife S.A.S. (Paris, France) secured $12 million in a series A round led by new investor Versant Ventures. New investor French National Institute of Health and Medical Research (Inserm) Transfert In...